Validation of a melasma quality of life questionnaire for the Turkish language: The MelasQoL-TR study

Journal of Dermatological Treatment

Volumn 20, Issue 2, 2009, Pages 95-99

  Dogramaci, Asena Cigdem ^a   Havlucu, Deniz Yurtman ^b   Inandi, Tacettin ^a   Balkrishnan, Rajesh ^c  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Dortyol State Hospital   (Turkey)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Melasma; Quality of life; Questionnaires; Turkish version; Validation

Indexed keywords

ADULT; ARTICLE; CHLOASMA; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MELASMA AREA AND SEVERITY INDEX; MELASMA QUALITY OF LIFE QUESTIONNAIRE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; VALIDATION STUDY; ADOLESCENT; AGE; ANALYSIS OF VARIANCE; LANGUAGE; MALE; MELANOSIS; PROBABILITY; PSYCHOLOGICAL ASPECT; PUBLICATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SICKNESS IMPACT PROFILE; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LANGUAGE; MALE; MELANOSIS; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SICKNESS IMPACT PROFILE; TRANSLATIONS; TURKEY; YOUNG ADULT;

EID: 67650327276     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802287553     Document Type: Article

References (16)

1. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18:91-8.
2. Sharquie KE, Al-Tikreety MM, Al-mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg. 2005;31:149-54.
3. Balkrishnan R, Mcmichael AJ, Hu JY, Camacho FT, Shew KR, Bouloc A, et al. Correlates of health-related quality of life in women with severe facial blemishes. Int j Dermatol. 2006;45:111-15.
4. Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren mm. Turkish version of Skindex-29. Int J Dermatol. 2007;46:350-5.
5. Ozturkcan S, Ermertcan T, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45:1300-7.
6. Balkrishnan R, Mcmichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149:572-7.
7. Kimbrough-Green CK, Griffths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-33.
8. The WhoQol. The development of the World Health Organization quality of life assessment instrument (the WHO-QOL). In: Orley J, Kuyken W, editors. Quality of life assessment: International perspectives. Heidelberg: Springer verlag; 1994. p. 41-60.
9. The WhoQol. Development of the World Health Organization WHOQOL-bref Quality of Life Assessment 1998. Psychol Med. 1998;28:551-8.
10. Eser E, Fidaner H, Fidaner C, Yalçin Eser S, Elbi H, Göker E. WHO QOL-100 ve WHOQOL-BREF'in psikometrik özellikleri. 3P Dergisi. 1999;7(ek 2): 23-40.
11. Skevington Sm, Lotfy m, O'connell KA, WhoQol GROUP. The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international feld trial. A Report from the WHOQOL Group. Qual Life Res. 2004;13:299-310.
12. Akvardar Y, Akdede BB, Ozerdem A, Eser E, Topkaya S, Alptekin K. Assessment of quality of life with the WHOQOL-BREF in a group of Turkish psychiatric patients compared with diabetic and healthy subjects. Psychiatry Clin Neurosci. 2006;60:693-9.
13. Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: Cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol. 2006;55:59-66.
14. Cestari TF, Hexsel D, Viegas ML, Azulay L, Hassun K, Almeida AR, et al. validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the melasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol. 2006;156(suppl 1):13-20.
15. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: A brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105-10.
16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-16.